Skip to content

Evidence-based treatment of drug users needed to strengthen human rights, stem drug use, and halt the HIV epidemic

Mass testing campaign unjustified if people fail to receive treatment, activist argues

Neurocognitive impairment linked to prior low CD4 cell count, even if on current suppressive HIV treatment

Good results seen with NRTI-sparing regimens of atazanavir plus newer drug classes

Prevention strategies need to target both early and chronic HIV infection

CASCADE analysis finds antiretroviral treatment benefits are evident below CD4 count of 500, uncertain above this level

Second-ever pre-exposure prophylaxis study reports no safety concerns and promising result

UK: one in six gay men testing HIV-positive were infected recently

Penal reform, decriminalisation of illicit drugs, and increased advocacy all central to improving prisoners' health